Clinical Trial Update: Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update noting the completion of Phase 2 and Phase 3 studies investigating noradrenergic manipulation combined with virtual reality exposure thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phobic Disorders

Snippet

Sponsor: VU University of Amsterdam | Conditions: Phobic Disorders | Phase 2, Phase 3 | Status: COMPLETED